mofebutazone

Description

mofebutazone · CAS 2210-63-1 · C13H16N2O2. UNII SPW36WUI5Z.

Identification

Computed Descriptors

GHS Hazard Classification

Documented Uses

• Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.
• M02 - Topical products for joint and muscular pain
• M02A - Topical products for joint and muscular pain
• M02AA - Antiinflammatory preparations, non-steroids for topical use
• M01 - Antiinflammatory and antirheumatic products
• M01A - Antiinflammatory and antirheumatic products, non-steroids

Synonyms

Mofebutazone; 2210-63-1; 4-butyl-1-phenylpyrazolidine-3,5-dione; Monophenylbutazone; Mophebutazone; 2 Fdbp; Mofebutazona; Mofebutazonum; Monazone; 4-Butyl-1-phenyl-3,5-pyrazolidinedione; 4-Butyl-1-phenyl-3,5-dioxopyrazolidine; SPW36WUI5Z; 2-Phenyl-3,5-dihydroxy-4-butylpyrazolidine; NSC-73725; DTXSID4023331; CHEBI:76252

Frequently Asked Questions

What are the CAS number and molecular formula of mofebutazone?

CAS 2210-63-1; molecular formula C13H16N2O2; molecular weight — g/mol.

What other names is mofebutazone known by?

Mofebutazone, 2210-63-1, 4-butyl-1-phenylpyrazolidine-3,5-dione, Monophenylbutazone, Mophebutazone, 2 Fdbp.

Is mofebutazone classified as hazardous?

Hazard statements reported: H302.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.